JP2024040951A5 - - Google Patents
Info
- Publication number
- JP2024040951A5 JP2024040951A5 JP2022145626A JP2022145626A JP2024040951A5 JP 2024040951 A5 JP2024040951 A5 JP 2024040951A5 JP 2022145626 A JP2022145626 A JP 2022145626A JP 2022145626 A JP2022145626 A JP 2022145626A JP 2024040951 A5 JP2024040951 A5 JP 2024040951A5
- Authority
- JP
- Japan
- Prior art keywords
- solid dispersion
- apalutamide
- enzalutamide
- pharmaceutical composition
- hesperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022145626A JP2024040951A (ja) | 2022-09-13 | 2022-09-13 | アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022145626A JP2024040951A (ja) | 2022-09-13 | 2022-09-13 | アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024040951A JP2024040951A (ja) | 2024-03-26 |
| JP2024040951A5 true JP2024040951A5 (enExample) | 2025-09-22 |
Family
ID=90369106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022145626A Pending JP2024040951A (ja) | 2022-09-13 | 2022-09-13 | アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2024040951A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025052925A1 (ja) * | 2023-09-08 | 2025-03-13 | 沢井製薬株式会社 | エンザルタミド固体分散体及びその製造方法、並びにエンザルタミド含有製剤及びその製造方法 |
| TR2024004340A1 (tr) * | 2024-04-05 | 2025-10-21 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Enzalutamidin katı dispersiyonu. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI673051B (zh) * | 2012-09-11 | 2019-10-01 | 美商梅維森前列腺療法有限責任公司 | 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物 |
| CN106102716A (zh) * | 2014-02-05 | 2016-11-09 | 斯洛文尼亚莱柯制药股份有限公司 | 雄激素受体拮抗剂的固体药物组合物 |
| PL3616696T3 (pl) * | 2017-04-28 | 2025-05-05 | Astellas Pharma Inc. | Kompozycja farmaceytczna do podawania doustnego zawierająca enzalutamid |
| WO2019016747A1 (en) * | 2017-07-20 | 2019-01-24 | Dr. Reddy's Laboratories Limited | AMORPHOUS SOLID DISPERSIONS OF APALUTAMIDE AND PROCESS FOR THEIR PREPARATION |
| JP7634525B2 (ja) * | 2019-09-23 | 2025-02-21 | バイオノミクス リミテッド | 治療用製剤およびその使用 |
| CA3206024A1 (en) * | 2021-02-01 | 2022-08-04 | The Global Alliance For Tb Drug Development, Inc. | Pretomanid amorphous form |
-
2022
- 2022-09-13 JP JP2022145626A patent/JP2024040951A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005324132B2 (en) | Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release | |
| EP0381219B1 (en) | Modified release gemfibrozil composition | |
| JP4749639B2 (ja) | 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法 | |
| IT9019571A1 (it) | Composizioni terapeutiche a rilascio controllato di farmaci supportati su polimeri reticolati e rivestiti con film polimerici, e loro processo di preparazione | |
| JP2009502487A5 (enExample) | ||
| JP2009502969A5 (enExample) | ||
| KR20110081316A (ko) | 디아세레인 함유 약제학적 조성물 | |
| JP2001520985A (ja) | 浸透圧性薬剤放出系 | |
| IT9020054A1 (enExample) | ||
| JP2007517050A5 (enExample) | ||
| CZ309994A3 (en) | Novel pharmaceutical preparation with diffusion-osmotic controlled release of a medicament and process for preparing thereof | |
| JP3017040B2 (ja) | トリメタジジンの経口投与用持続的放出型薬剤組成物 | |
| EP0381218B1 (en) | Extended release gemfibrozil composition | |
| US6602522B1 (en) | Pharmaceutical formulation for acid-labile compounds | |
| WO2011160541A1 (zh) | 托伐普坦固体分散体及其制备方法 | |
| WO2015145462A1 (en) | Pharmaceutical compositions of dabigatran | |
| JPS6248618A (ja) | 徐放性製剤およびその製造法 | |
| WO1997033574A1 (fr) | Comprimes a liberation prolongee a base de valproate metallique | |
| KR20110113940A (ko) | 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 한 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물 | |
| US20080146615A1 (en) | Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds | |
| JP2020519669A5 (enExample) | ||
| CN106999442A (zh) | 用于制备药物‑聚合物组合物的方法 | |
| CN102552205B (zh) | 一种枸橼酸钾控释片制剂及其制备方法 | |
| RU2024110714A (ru) | Фармацевтические композиции на основе дидрогестерона с пролонгированным высвобождением | |
| CN100496486C (zh) | 一种难溶性药物的控释制剂 |